{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:31:00Z","timestamp":1789471860315,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the association between fat distribution and 10-year cardiovascular disease (CVD) risk, and to evaluate the mediating roles of inflammatory markers in this relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were obtained from the 2017\u20132018 cycle of the National Health and Nutrition Examination Survey (NHANES), including 4,741 participants aged\u2009\u2265\u200930 years. Fat distribution was assessed using body mass index (BMI), waist circumference (WC), and regional fat percentages (upper limbs, lower limbs, trunk, and total body) measured via dual-energy X-ray absorptiometry (DXA). The Framingham Risk Score (FRS) was used to estimate 10-year cardiovascular disease (CVD) risk. Multivariable linear regression models were applied to evaluate the associations between fat distribution and FRS. In addition, mediation analysis was performed to assess the indirect effects of inflammatory markers\u2014including C-reactive protein (CRP), white blood cell count (WBC), and neutrophil-to-lymphocyte ratio (NLR)\u2014on the relationship between fat distribution and FRS. All analyses were stratified by sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In men, the total fat percentage showed the strongest positive correlation with the Framingham Risk Score (FRS) (\u03b2\u2009=\u20090.08, 95% CI: 0.07\u20130.10), followed by the trunk fat percentage (\u03b2\u2009=\u20090.09, 95% CI: 0.08\u20130.11) and BMI (\u03b2\u2009=\u20090.07, 95% CI: 0.06\u20130.08). C-reactive protein (CRP) exhibited a significant mediating effect in the relationship between total fat and FRS (indirect effect\u2009=\u20090.019, 95% CI: 0.015\u20130.025), with a mediation proportion of 23.1%.<\/jats:p>\n                    <jats:p>In women, total fat percentage demonstrated a significant \"U-shaped\" nonlinear relationship with FRS (P_nonlinear = 0.046), with risk increasing sharply when body fat exceeded approximately 35%. In the fully adjusted model, the three major fat distribution indicators influencing FRS were total fat percentage (\u03b2= 0.11, 95% CI: 0.07\u20130.14), trunk fat percentage (\u03b2 = 0.11, 95% CI: 0.07\u20130.14), and BMI (\u03b2 = 0.09, 95% CI: 0.07\u20130.11). The mediating effect of CRP was the most significant (indirect effect = 0.041, 95% CI: 0.031\u20130.054), with a mediation proportion of 38.1%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Different fat distribution patterns exert varying influences on long-term cardiovascular risk, with total body fat percentage showing the strongest association with increased risk. Inflammatory responses may serve as key biological mediators linking fat distribution to cardiovascular disease (CVD), highlighting the importance of monitoring and managing inflammation to reduce CVD risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-025-05135-3","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:38:42Z","timestamp":1758875922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fat distribution, inflammatory mechanisms, and cardiovascular disease risk: mediation analysis based on the Framingham risk score"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhuangzhuang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"1","key":"5135_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12889-021-10781-1","volume":"17","author":"SN Tulu","year":"2021","unstructured":"Tulu SN, Al Salmi N, Jones J. Understanding cardiovascular disease in day-to-day living for African people: a qualitative metasynthesis. BMC Public Health Apr. 2021;17(1):745. https:\/\/doi.org\/10.1186\/s12889-021-10781-1.","journal-title":"BMC Public Health Apr"},{"key":"5135_CR2","doi-asserted-by":"publisher","first-page":"100130","DOI":"10.1016\/j.ajpc.2020.100130","volume":"4","author":"A Alfaddagh","year":"2020","unstructured":"Alfaddagh A, Martin SS, Leucker TM, et al. Inflammation and cardiovascular disease: from mechanisms to therapeutics. Am J Prev Cardiol Dec. 2020;4:100130. https:\/\/doi.org\/10.1016\/j.ajpc.2020.100130.","journal-title":"Am J Prev Cardiol Dec"},{"key":"5135_CR3","doi-asserted-by":"publisher","first-page":"e59392","DOI":"10.2196\/59392","volume":"24","author":"A Brahma","year":"2024","unstructured":"Brahma A, Chatterjee S, Seal K, Fitzpatrick B, Tao Y. Development of a cohort analytics tool for monitoring progression patterns in cardiovascular diseases: advanced stochastic modeling approach. JMIR Med Inform Sep. 2024;24:12:e59392. https:\/\/doi.org\/10.2196\/59392.","journal-title":"JMIR Med Inform Sep"},{"issue":"3","key":"5135_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2174\/1573403X14666180222102312","volume":"14","author":"S Francula-Zaninovic","year":"2018","unstructured":"Francula-Zaninovic S, Nola IA. Management of measurable variable cardiovascular disease\u2019 risk factors. Curr Cardiol Rev. 2018;14(3):153\u201363. https:\/\/doi.org\/10.2174\/1573403X14666180222102312.","journal-title":"Curr Cardiol Rev"},{"key":"5135_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12913-016-1420-8","volume":"10","author":"W Stevens","year":"2016","unstructured":"Stevens W, Peneva D, Li JZ, et al. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res May. 2016;10:16:175. https:\/\/doi.org\/10.1186\/s12913-016-1420-8.","journal-title":"BMC Health Serv Res May"},{"issue":"19","key":"5135_CR6","doi-asserted-by":"publisher","first-page":"e016115","DOI":"10.1161\/JAHA.120.016115","volume":"20","author":"HC Gooding","year":"2020","unstructured":"Gooding HC, Gidding SS, Moran AE, et al. Challenges and opportunities for the prevention and treatment of cardiovascular disease among young adults: report from a National heart, lung, and blood Institute working group. J Am Heart Assoc. Oct 2020;20(19):e016115. https:\/\/doi.org\/10.1161\/JAHA.120.016115.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"5135_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000368783","volume":"7","author":"JE Blundell","year":"2014","unstructured":"Blundell JE, Dulloo AG, Salvador J, Fruhbeck G, BMI ESWGo. Beyond BMI\u2013phenotyping the obesities. Obes Facts. 2014;7(5):322\u20138. https:\/\/doi.org\/10.1159\/000368783.","journal-title":"Obes Facts"},{"key":"5135_CR8","doi-asserted-by":"publisher","unstructured":"Wu Y, Li D, Vermund SH. Advantages and limitations of the body mass index (BMI) to assess adult obesity. Int J Environ Res Public Health Jun. 2024;10(6). https:\/\/doi.org\/10.3390\/ijerph21060757.","DOI":"10.3390\/ijerph21060757"},{"key":"5135_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-5-1","volume":"13","author":"AR Baker","year":"2006","unstructured":"Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol Jan. 2006;13:5:1. https:\/\/doi.org\/10.1186\/1475-2840-5-1.","journal-title":"Cardiovasc Diabetol Jan"},{"issue":"2","key":"5135_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5505\/kjms.2024.86300","volume":"14","author":"M Karakayal\u0131","year":"2024","unstructured":"Karakayal\u0131 M, Altunova M, Yakisan T, et al. Relationship between nonobstructive coronary arteries and metabolic parameters. Kafkas J Med Sci. 2024;14(2):138\u201343. https:\/\/doi.org\/10.5505\/kjms.2024.86300.","journal-title":"Kafkas J Med Sci"},{"issue":"2","key":"5135_CR11","doi-asserted-by":"publisher","first-page":"e20230540","DOI":"10.36660\/abc.20230540","volume":"121","author":"M Karakayali","year":"2024","unstructured":"Karakayali M, Altunova M, Yakisan T, et al. The relationship between the systemic Immune-Inflammation index and ischemia with Non-Obstructive coronary arteries in patients undergoing coronary angiography. Arq Bras Cardiol. 2024;121(2):e20230540. https:\/\/doi.org\/10.36660\/abc.20230540. A Relacao entre o Indice de Imuno-Inflamacao Sistemica e Isquemia com Arterias Coronarias Nao Obstrutivas em Pacientes Submetidos a Angiografia Coronaria.","journal-title":"Arq Bras Cardiol"},{"key":"5135_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. https:\/\/doi.org\/10.3389\/fcvm.2020.00022.","journal-title":"Front Cardiovasc Med"},{"key":"5135_CR13","doi-asserted-by":"publisher","unstructured":"Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010doi. https:\/\/doi.org\/10.1155\/2010\/289645.","DOI":"10.1155\/2010\/289645"},{"issue":"11","key":"5135_CR14","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1210\/jc.2017-01113","volume":"1","author":"M Mongraw-Chaffin","year":"2017","unstructured":"Mongraw-Chaffin M, Allison MA, Burke GL, et al. CT-Derived body fat distribution and incident cardiovascular disease: the Multi-Ethnic study of atherosclerosis. J Clin Endocrinol Metab Nov. 2017;1(11):4173\u201383. https:\/\/doi.org\/10.1210\/jc.2017-01113.","journal-title":"J Clin Endocrinol Metab Nov"},{"issue":"1","key":"5135_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","volume":"116","author":"CS Fox","year":"2007","unstructured":"Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39\u201348.","journal-title":"Circulation"},{"key":"5135_CR16","doi-asserted-by":"publisher","unstructured":"Gradidge PJ, Jaff NG, Norris SA, Toman M, Crowther NJ. The negative association of lower body fat mass with cardiometabolic disease risk factors is partially mediated by adiponectin. Endocr Connect Dec. 2022;1(12). https:\/\/doi.org\/10.1530\/EC-22-0156.","DOI":"10.1530\/EC-22-0156"},{"key":"5135_CR17","doi-asserted-by":"publisher","first-page":"889923","DOI":"10.3389\/fendo.2022.889923","volume":"13","author":"BM Steiner","year":"2022","unstructured":"Steiner BM, Berry DC. The regulation of adipose tissue health by estrogens. Front Endocrinol (Lausanne). 2022;13:889923. https:\/\/doi.org\/10.3389\/fendo.2022.889923.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"5135_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.biocel.2009.12.009","volume":"42","author":"M Ahmadian","year":"2010","unstructured":"Ahmadian M, Wang Y, Sul HS. Lipolysis in adipocytes. Int J Biochem Cell Biol May. 2010;42(5):555\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2009.12.009.","journal-title":"Int J Biochem Cell Biol May"},{"key":"5135_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2014.00470","volume":"5","author":"MJ Kraakman","year":"2014","unstructured":"Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophage polarization in obesity and type 2 diabetes: weighing down our Understanding of macrophage function? Front Immunol. 2014;5:470. https:\/\/doi.org\/10.3389\/fimmu.2014.00470.","journal-title":"Front Immunol"},{"key":"5135_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","volume":"15","author":"BF Palmer","year":"2015","unstructured":"Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol Feb. 2015;15:402:113\u20139. https:\/\/doi.org\/10.1016\/j.mce.2014.11.029.","journal-title":"Mol Cell Endocrinol Feb"},{"issue":"2","key":"5135_CR21","doi-asserted-by":"publisher","first-page":"e0193368","DOI":"10.1371\/journal.pone.0193368","volume":"13","author":"B Dong","year":"2018","unstructured":"Dong B, Peng Y, Wang Z, et al. Joint association between body fat and its distribution with all-cause mortality: A data linkage cohort study based on NHANES (1988\u20132011). PLoS ONE. 2018;13(2):e0193368. https:\/\/doi.org\/10.1371\/journal.pone.0193368.","journal-title":"PLoS ONE"},{"issue":"4","key":"5135_CR22","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/ijo.2017.289","volume":"42","author":"SK Vasan","year":"2018","unstructured":"Vasan SK, Osmond C, Canoy D, et al. Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk. Int J Obes (Lond) Apr. 2018;42(4):850\u20137. https:\/\/doi.org\/10.1038\/ijo.2017.289.","journal-title":"Int J Obes (Lond) Apr"},{"issue":"3","key":"5135_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.surg.2008.08.038","volume":"145","author":"RW O\u2019Rourke","year":"2009","unstructured":"O\u2019Rourke RW. Inflammation in obesity-related diseases. Surgery Mar. 2009;145(3):255\u20139. https:\/\/doi.org\/10.1016\/j.surg.2008.08.038.","journal-title":"Surgery Mar"},{"issue":"9","key":"5135_CR24","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1172\/JCI34260","volume":"118","author":"S Schenk","year":"2008","unstructured":"Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest Sep. 2008;118(9):2992\u20133002. https:\/\/doi.org\/10.1172\/JCI34260.","journal-title":"J Clin Invest Sep"},{"issue":"11","key":"5135_CR25","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/oby.21659","volume":"24","author":"G Zong","year":"2016","unstructured":"Zong G, Zhang Z, Yang Q, Wu H, Hu FB, Sun Q. Total and regional adiposity measured by dual-energy X-ray absorptiometry and mortality in NHANES 1999\u20132006. Obesity (Silver Spring) Nov. 2016;24(11):2414\u201321. https:\/\/doi.org\/10.1002\/oby.21659.","journal-title":"Obesity (Silver Spring) Nov"},{"issue":"2","key":"5135_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MCA.0000000000000564","volume":"29","author":"L Askin","year":"2018","unstructured":"Askin L, Cetin M, Turkmen S. Absence of a correlation between the ABO blood group and thrombus burden in patients with ST-segment elevation myocardial infarction. Coron Artery Dis Mar. 2018;29(2):145\u201350. https:\/\/doi.org\/10.1097\/MCA.0000000000000564.","journal-title":"Coron Artery Dis Mar"},{"issue":"7","key":"5135_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/MCA.0000000000001271","volume":"1","author":"M Karakayali","year":"2023","unstructured":"Karakayali M, Omar T, Artac I, et al. The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis Nov. 2023;1(7):483\u20138. https:\/\/doi.org\/10.1097\/MCA.0000000000001271.","journal-title":"Coron Artery Dis Nov"},{"issue":"3","key":"5135_CR28","doi-asserted-by":"publisher","first-page":"e60008","DOI":"10.1371\/journal.pone.0060008","volume":"8","author":"SC Chen","year":"2013","unstructured":"Chen SC, Su HM, Tsai YC, et al. Framingham risk score with cardiovascular events in chronic kidney disease. PLoS ONE. 2013;8(3):e60008. https:\/\/doi.org\/10.1371\/journal.pone.0060008.","journal-title":"PLoS ONE"},{"key":"5135_CR29","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.lanwpc.2023.100742","volume":"35","author":"SS Kasim","year":"2023","unstructured":"Kasim SS, Ibrahim N, Malek S, et al. Validation of the general Framingham risk score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population. Lancet Reg Health West Pac Jun. 2023;35:100742. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100742.","journal-title":"Lancet Reg Health West Pac Jun"},{"issue":"7","key":"5135_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41393-020-00566-5","volume":"59","author":"MC Dorton","year":"2021","unstructured":"Dorton MC, Lucci VM, de Groot S, et al. Evaluation of cardiovascular disease risk in individuals with chronic spinal cord injury. Spinal Cord Jul. 2021;59(7):716\u201329. https:\/\/doi.org\/10.1038\/s41393-020-00566-5.","journal-title":"Spinal Cord Jul"},{"issue":"3","key":"5135_CR31","doi-asserted-by":"publisher","first-page":"204589402095201","DOI":"10.1177\/2045894020952023","volume":"10","author":"KM Mair","year":"2020","unstructured":"Mair KM, Gaw R, MacLean MR. Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension. Pulm Circ Jul-Sep. 2020;10(3):2045894020952019. https:\/\/doi.org\/10.1177\/2045894020952023.","journal-title":"Pulm Circ Jul-Sep"},{"key":"5135_CR32","doi-asserted-by":"publisher","first-page":"1368966","DOI":"10.3389\/fnut.2024.1368966","volume":"11","author":"M Alser","year":"2024","unstructured":"Alser M, Naja K, Elrayess MA. Mechanisms of body fat distribution and gluteal-femoral fat protection against metabolic disorders. Front Nutr. 2024;11:1368966. https:\/\/doi.org\/10.3389\/fnut.2024.1368966.","journal-title":"Front Nutr"},{"issue":"4","key":"5135_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5114\/pm.2021.110954","volume":"20","author":"F Mulita","year":"2021","unstructured":"Mulita F, Lampropoulos C, Kehagias D, et al. Long-term nutritional deficiencies following sleeve gastrectomy: a 6-year single-centre retrospective study. Prz Menopauzalny Dec. 2021;20(4):170\u20136. https:\/\/doi.org\/10.5114\/pm.2021.110954.","journal-title":"Prz Menopauzalny Dec"},{"issue":"10","key":"5135_CR34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1055\/s-2007-985898","volume":"39","author":"JS Yudkin","year":"2007","unstructured":"Yudkin JS. Inflammation, obesity, and the metabolic syndrome. Horm Metab Res Oct. 2007;39(10):707\u20139. https:\/\/doi.org\/10.1055\/s-2007-985898.","journal-title":"Horm Metab Res Oct"},{"key":"5135_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-016-0095-9","volume":"13","author":"X Gao","year":"2016","unstructured":"Gao X, Zhang W, Wang Y, et al. Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals. Nutr Metab (Lond). 2016;13:33. https:\/\/doi.org\/10.1186\/s12986-016-0095-9.","journal-title":"Nutr Metab (Lond)"},{"key":"5135_CR36","doi-asserted-by":"publisher","first-page":"1446964","DOI":"10.3389\/fcell.2024.1446964","volume":"12","author":"Y Dai","year":"2024","unstructured":"Dai Y, Junho CVC, Schieren L, et al. Cellular metabolism changes in atherosclerosis and the impact of comorbidities. Front Cell Dev Biol. 2024;12:1446964. https:\/\/doi.org\/10.3389\/fcell.2024.1446964.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"5135_CR37","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov Aug. 2021;20(8):589\u2013610. https:\/\/doi.org\/10.1038\/s41573-021-00198-1.","journal-title":"Nat Rev Drug Discov Aug"},{"key":"5135_CR38","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2017.00928","volume":"8","author":"H Qi","year":"2017","unstructured":"Qi H, Yang S, Zhang L. Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis. Front Immunol. 2017;8:928. https:\/\/doi.org\/10.3389\/fimmu.2017.00928.","journal-title":"Front Immunol"},{"issue":"2","key":"5135_CR39","doi-asserted-by":"publisher","first-page":"e00346520","DOI":"10.1590\/0102-311X00346520","volume":"38","author":"BBR Oliveira","year":"2022","unstructured":"Oliveira BBR, Coelho CG, Barreto SM, Giatti L, Araujo LF. Body fat distribution and its risk for cardiovascular events in 10 years: Brazilian longitudinal study of adult health (ELSA-Brasil). Cad Saude Publica. 2022;38(2):e00346520. https:\/\/doi.org\/10.1590\/0102-311X00346520.","journal-title":"Cad Saude Publica"},{"issue":"4","key":"5135_CR40","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/oby.20028","volume":"21","author":"X Zhang","year":"2013","unstructured":"Zhang X, Hu EA, Wu H, Malik V, Sun Q. Associations of leg fat accumulation with adiposity-related biological factors and risk of metabolic syndrome. Obesity (Silver Spring) Apr. 2013;21(4):824\u201330. https:\/\/doi.org\/10.1002\/oby.20028.","journal-title":"Obesity (Silver Spring) Apr"},{"issue":"4","key":"5135_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/21623945.2018.1525252","volume":"7","author":"AD Booth","year":"2018","unstructured":"Booth AD, Magnuson AM, Fouts J, et al. Subcutaneous adipose tissue accumulation protects systemic glucose tolerance and muscle metabolism. Adipocyte. 2018;7(4):261\u201372. https:\/\/doi.org\/10.1080\/21623945.2018.1525252.","journal-title":"Adipocyte"},{"issue":"1","key":"5135_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.ebd.6400375","volume":"7","author":"KA Levin","year":"2006","unstructured":"Levin KA. Study design III: Cross-sectional studies. Evid Based Dent. 2006;7(1):24\u20135. https:\/\/doi.org\/10.1038\/sj.ebd.6400375.","journal-title":"Evid Based Dent"},{"issue":"11","key":"5135_CR43","doi-asserted-by":"publisher","first-page":"e0187189","DOI":"10.1371\/journal.pone.0187189","volume":"12","author":"J Lee","year":"2017","unstructured":"Lee J, Lee S, Zhang H, Hill MA, Zhang C, Park Y. Interaction of IL-6 and TNF-alpha contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS ONE. 2017;12(11):e0187189. https:\/\/doi.org\/10.1371\/journal.pone.0187189.","journal-title":"PLoS ONE"},{"issue":"3","key":"5135_CR44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1042\/CS20080196","volume":"116","author":"H Zhang","year":"2009","unstructured":"Zhang H, Park Y, Wu J, et al. Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) Feb. 2009;116(3):219\u201330. https:\/\/doi.org\/10.1042\/CS20080196.","journal-title":"Clin Sci (Lond) Feb"},{"key":"5135_CR45","doi-asserted-by":"publisher","unstructured":"Mulita F, Verras GI, Anagnostopoulos CN, Kotis K. A smarter health through the internet of surgical things. Sensors (Basel) Jun. 2022;17(12). https:\/\/doi.org\/10.3390\/s22124577.","DOI":"10.3390\/s22124577"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05135-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:38:43Z","timestamp":1758875923000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05135-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5135"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05135-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6686803\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a secondary analysis of publicly available data from the NHANES 2017\u20132018 cycle, conducted by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC), United States. The NHANES protocol was reviewed and approved by the NCHS Research Ethics Review Board, and written informed consent was obtained from all participants. All procedures involving human participants followed the ethical standards of the 1964 Declaration of Helsinki and its later amendments. As this study involved only de-identified secondary data, no additional ethical approval was required.\u00a0The present study used publicly available, de-identified NHANES data for secondary analysis, with informed consent already obtained by NHANES investigators.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}